| Makale Türü | Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale) | ||
| Dergi Adı | European Journal of Pharmacology | ||
| Dergi ISSN | 0014-2999 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 01-2018 |
| Cilt / Sayı / Sayfa | 818 / 1 / 457–469 | DOI | 10.1016/j.ejphar.2017.11.011 |
| Makale Linki | https://linkinghub.elsevier.com/retrieve/pii/S0014299917307367 | ||
| Özet |
| This study aimed to investigate the potential role of urotensin-II receptors in sepsis-induced lung injury in diabetic mice using urotensin-II receptor agonists and antagonists. A total of 110 male CD1 mice were used in this study. Diabetes was induced by 200 mg/kg streptozotocin. One month after diabetes induction, the cecal ligation and puncture-induced polymicrobial sepsis model was applied in the diabetic and non-diabetic mice. Low and high doses of human urotensin-II agonist (HU-II) and antagonist (palosuran) were administered one hour after sepsis induction. HU-II administration was repeated in two-hour intervals. Blood and tissue samples were collected at 6 and 12H after sepsis induction for biochemical, molecular, and histopathologic examinations. Regarding to the lungs mRNA expression and immunohistochemistry results of TNF-α, IL1 β, IL6, and NF-κ B, it was observed that cytokine levels … |
| Anahtar Kelimeler |
| Diabetes | Lung | Mice | Palosuran | Sepsis | Urotensin-II |
| Atıf Sayıları | |
| Web of Science | 31 |
| Scopus | 32 |
| Google Scholar | 41 |
| Dergi Adı | European Journal of Pharmacology |
| Yayıncı | Elsevier B.V. |
| Açık Erişim | Hayır |
| ISSN | 0014-2999 |
| E-ISSN | 1879-0712 |
| CiteScore | 8,4 |
| SJR | 1,197 |
| SNIP | 0,980 |